DOI:
10.1055/s-00026982
Urologie Scan
LinksClose Window
References
Herbst RS, Baas P, Kim DW et al.
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.
Lancet 18.12.2015; pii: S0140-6736(15)01281-7.
DOI: 10.1016/S0140-6736(15)01281-7.
We do not assume any responsibility for the contents of the web pages of other providers.